Delivery Order SPE2DB22D2006-SPE2DB24FW1LX

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division. The $3,612.60 firm fixed-price contract is for the delivery of Insulin Degludec Pens (U-100) 3ML, a critical medical supply. The contract has no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,710.72 firm fixed price contract is for the supply of insulin degludec pens (U-100, 3 mL) to support military treatment facilities and federal healthcare programs. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Insulin Degludec Pens (U-200) 3ML to the U.S. government. The $1,257.03 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical commodities,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of insulin degludec pens (U-100, 3 mL) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,403.70 and a completion date of May 8, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a particular focus on serving the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
This federal contract award, valued at $1,165.68, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Insulin Degludec Pen (U-200) 3ML, a critical pharmaceutical product. This delivery order award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.84 Firm Fixed Price Delivery Order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of August 22, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-100, 3 mL). The contract is a delivery order with a firm fixed price of $1,288.93 and a completion date of May 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for...
The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract (SPE2DX15D2101|SPE2DX24F50XW) worth $1,647.60 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00 from the...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1LX
    Delivery Order

This is a $2,042.47 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of Insulin Degludec Pens (U-100) 3ML, a critical medical product used to manage diabetes.

AmerisourceBergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This particular delivery order does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a significant supplier of pharmaceuticals and medical supplies to the federal government, AmerisourceBergen leverages its extensive supply chain network to efficiently fulfill these types of government contracts.

Generated 9/27/24, 9:22 AM